{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:18:00Z","timestamp":1784733480900,"version":"3.55.0"},"reference-count":58,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2023.2651","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T08:54:51Z","timestamp":1685004891000},"source":"Crossref","is-referenced-by-count":14,"title":["Conservative treatment of endometrial cancer in women of reproductive age (Review)"],"prefix":"10.3892","volume":"19","author":[{"given":"Maria Zoi","family":"Bourou","sequence":"first","affiliation":[{"name":"Second Department of Obstetrics and Gynecology, Aretaieio University Hospital, National and Kapodistrian University of Athens Medical School, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkis","family":"Matsas","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gynecology, Aretaieio University Hospital, National and Kapodistrian University of Athens Medical School, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vrekoussis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical School, University of Crete, 71500 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mastorakos","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gynecology, Aretaieio University Hospital, National and Kapodistrian University of Athens Medical School, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Valsamakis","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gynecology, Aretaieio University Hospital, National and Kapodistrian University of Athens Medical School, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Panoskaltsis","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gynecology, Aretaieio University Hospital, National and Kapodistrian University of Athens Medical School, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"key20230628100438_b1-MCO-19-1-02651","first-page":"448","article-title":"Risk factors for endometrial cancer","volume":"78","author":"Ali","year":"2013","journal-title":"Ceska Gynekol"},{"key":"key20230628100438_b2-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jmig.2017.07.022","article-title":"Updates on conservative management of endometrial cancer","volume":"25","author":"Corzo","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"key":"key20230628100438_b3-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/IJWH.S47232","article-title":"Preserving fertility in young patients with endometrial cancer: Current perspectives","volume":"6","author":"Kalogera","year":"2014","journal-title":"Int J Womens Health"},{"issue":"892","key":"key20230628100438_b4-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2019.892","article-title":"Conservative treatment for well-differentiated endometrial cancer: When and why it should be considered in young women","volume":"13","author":"Peiretti","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"key20230628100438_b5-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann Oncol"},{"key":"key20230628100438_b6-MCO-19-1-02651","first-page":"468","article-title":"Diagnosis and management of endometrial cancer","volume":"93","author":"Braun","year":"2016","journal-title":"Am Fam Physician"},{"key":"key20230628100438_b7-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5468\/ogs.19169","article-title":"Fertility-sparing treatment in early endometrial cancer: Current state and future strategies","volume":"63","author":"Obermair","year":"2020","journal-title":"Obstet Gynecol Sci"},{"key":"key20230628100438_b8-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"405","DOI":"10.23750\/abm.v90i4.7800","article-title":"Conservative treatment in early stage endometrial cancer: A review","volume":"90","author":"Trojano","year":"2019","journal-title":"Acta Biomed"},{"key":"key20230628100438_b9-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1200\/EDBK_175666","article-title":"Endometrial cancer: Is this a new disease?","volume":"37","author":"Moore","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20230628100438_b10-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1097\/IGC.0000000000000493","article-title":"European society of gynecological oncology task force for fertility preservation: Clinical recommendations for fertility-sparing management in young endometrial cancer patients","volume":"25","author":"Rodolakis","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"key20230628100438_b11-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejogrb.2017.04.015","article-title":"BGCS uterine cancer guidelines: Recommendations for practice","volume":"213","author":"Sundar","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20230628100438_b12-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/RCT.0000000000001025","article-title":"Endometrial cancer, the current international federation of gynecology and obstetrics staging system, and the role of imaging","volume":"44","author":"Saleh","year":"2020","journal-title":"J Comput Assist Tomogr"},{"key":"key20230628100438_b13-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concil","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1030","key":"key20230628100438_b14-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2020.1030","article-title":"Fertility preservation in endometrial cancer patients: Options, challenges and perspectives","volume":"14","author":"Terzic","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"key20230628100438_b15-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"S2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::aid-cncr2820601515>3.0.co;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study","volume":"60 (8 Suppl)","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"key20230628100438_b16-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2020.02.021","article-title":"Lymph node metastasis probability in young patients eligible for conservative management of endometrial cancer","volume":"157","author":"Gonthier","year":"2020","journal-title":"Gynecol Oncol"},{"key":"key20230628100438_b17-MCO-19-1-02651","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F","article-title":"The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: A meta-analysis","volume":"89","author":"Dijkhuizen","year":"2000","journal-title":"Cancer"},{"key":"key20230628100438_b18-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ygyno.2008.12.017","article-title":"Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma","volume":"113","author":"Leitao","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3571","key":"key20230628100438_b19-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123571","article-title":"Fertility sparing treatment of endometrial cancer with and without initial infiltration of myometrium: A single center experience","volume":"12","author":"Casadio","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20230628100438_b20-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00404-014-3585-x","article-title":"Hysteroscopy in women with abnormal uterine bleeding: A meta-analysis on four major endometrial pathologies","volume":"291","author":"Gkorzou","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"key20230628100438_b21-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1148\/radiology.216.2.r00au17444","article-title":"Prediction of deep myometrial invasion in patients with endometrial cancer: Clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis","volume":"216","author":"Frei","year":"2000","journal-title":"Radiology"},{"issue":"e86","key":"key20230628100438_b22-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e86","article-title":"Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: A systematic review and meta-analysis","volume":"28","author":"Alc\u00e1zar","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"key20230628100438_b23-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.12659\/MSM.915276","article-title":"Magnetic resonance imaging (MRI) and three-dimensional transvaginal ultrasonography scanning for preoperative assessment of high risk in women with endometrial cancer","volume":"25","author":"Yang","year":"2019","journal-title":"Med Sci Monit"},{"key":"key20230628100438_b24-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/hropen\/hoac057","article-title":"ESGO\/ESHRE\/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"33","author":"Rodolakis","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"505","key":"key20230628100438_b25-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2015.505","article-title":"Hysteroscopic surgery for conservative management in endometrial cancer: A review of the literature","volume":"9","author":"Alonso","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"key20230628100438_b26-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1136\/ijgc-2021-002699","article-title":"Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: A systematic review and meta-analysis","volume":"31","author":"Chae-Kim","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"e90","key":"key20230628100438_b27-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e90","article-title":"Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients","volume":"30","author":"Mitsuhashi","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"2559","key":"key20230628100438_b28-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092559","article-title":"Insulin resistance and endometrial cancer: Emerging role for microRNA","volume":"12","author":"Sidorkiewicz","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20230628100438_b29-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.2147\/CMAR.S188087","article-title":"Fertility-preserving treatment in women with early endometrial cancer: The Chinese experience","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag Res"},{"key":"key20230628100438_b30-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1634\/theoncologist.2013-0445","article-title":"Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer","volume":"20","author":"Park","year":"2015","journal-title":"Oncologist"},{"issue":"381","key":"key20230628100438_b31-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2013.381","article-title":"Progesterone receptor isoforms A and B: New insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma","volume":"7","author":"Shao","year":"2013","journal-title":"Ecancermedicalscience"},{"issue":"12248","key":"key20230628100438_b32-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212248","article-title":"Fertility sparing treatments in endometrial cancer patients: The potential role of the new molecular classification","volume":"22","author":"Cavaliere","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20230628100438_b33-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"55","DOI":"10.23736\/S0026-4806.20.07072-X","article-title":"Fertility-sparing management for endometrial cancer: Review of the literature","volume":"112","author":"Garzon","year":"2021","journal-title":"Minerva Med"},{"key":"key20230628100438_b34-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"669.e1","DOI":"10.1016\/j.ajog.2017.08.007","article-title":"All-cause mortality in young women with endometrial cancer receiving progesterone therapy","volume":"217","author":"Ruiz","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"key20230628100438_b35-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/aogs.13587","article-title":"Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review","volume":"98","author":"Travaglino","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"602","key":"key20230628100438_b36-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040602","article-title":"The perspectives of fertility preservation in women with endometrial cancer","volume":"13","author":"Knez","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20230628100438_b37-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key20230628100438_b38-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/1471-0528.16108","article-title":"Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: A randomised controlled trial","volume":"127","author":"Yang","year":"2020","journal-title":"BJOG"},{"issue":"e79","key":"key20230628100438_b39-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e79","article-title":"The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia","volume":"30","author":"Chen","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"e32","key":"key20230628100438_b40-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e32","article-title":"Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: A prospective, open-label, randomized control phase II trial (ClinicalTrials.gov NCT03241914)","volume":"34","author":"Xu","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"1256","key":"key20230628100438_b41-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58091256","article-title":"Conservative management of atypical endometrial hyperplasia and early endometrial cancer in childbearing age women","volume":"58","author":"Uccella","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"341","key":"key20230628100438_b42-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00341","article-title":"Metformin as a therapeutic target in endometrial cancers","volume":"8","author":"Lee","year":"2018","journal-title":"Front Oncol"},{"issue":"744689","key":"key20230628100438_b43-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.744689","article-title":"Insulin resistance and metabolic syndrome increase the risk of relapse for fertility preserving treatment in atypical endometrial hyperplasia and early endometrial cancer patients","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"issue":"206","key":"key20230628100438_b44-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-022-01513-8","article-title":"Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: A prospective, randomized, blind-endpoint design trial protocol","volume":"19","author":"Zhao","year":"2022","journal-title":"Reprod Health"},{"key":"key20230628100438_b45-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.fertnstert.2008.12.009","article-title":"Conservative surgical management of stage IA endometrial carcinoma for fertility preservation","volume":"93","author":"Mazzon","year":"2010","journal-title":"Fertil Steril"},{"key":"key20230628100438_b46-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jmig.2018.07.001","article-title":"Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: A retrospective study","volume":"26","author":"Giampaolino","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"key20230628100438_b47-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ygyno.2019.01.014","article-title":"Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer","volume":"153","author":"Yang","year":"2019","journal-title":"Gynecol Oncol"},{"key":"key20230628100438_b48-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ygyno.2021.04.017","article-title":"Updates on conservative management of endometrial cancer in patients younger than 45 years","volume":"161","author":"Lucchini","year":"2021","journal-title":"Gynecol Oncol"},{"key":"key20230628100438_b49-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5935\/1518-0557.20160045","article-title":"Fertility-preservation in endometrial cancer: Is it safe? Review of the literature","volume":"20","author":"Carneiro","year":"2016","journal-title":"JBRA Assist Reprod"},{"issue":"5187","key":"key20230628100438_b50-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215187","article-title":"Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes","volume":"14","author":"Mutlu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20230628100438_b51-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"474.e1","DOI":"10.1016\/j.ajog.2019.05.029","article-title":"National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia","volume":"221","author":"Harrison","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"118","key":"key20230628100438_b52-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00808-y","article-title":"Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia","volume":"19","author":"Fan","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"key20230628100438_b53-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/humupd\/dmab041","article-title":"Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: A systematic review and meta-analysis","volume":"28","author":"Herrera Cappelletti","year":"2022","journal-title":"Hum Reprod Update"},{"key":"key20230628100438_b54-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tjog.2009.10.006","article-title":"Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: Case series and literature review","volume":"50","author":"Chao","year":"2011","journal-title":"Taiwan J Obstet Gynecol"},{"key":"key20230628100438_b55-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ygyno.2019.03.098","article-title":"Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma","volume":"153","author":"Britton","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"965029","key":"key20230628100438_b56-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.965029","article-title":"Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer","volume":"12","author":"Ronsini","year":"2022","journal-title":"Front Oncol"},{"issue":"e74","key":"key20230628100438_b57-MCO-19-1-02651","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e74","article-title":"Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: A gynecologic cancer inter-group (GCIG) study","volume":"31","author":"Falcone","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"key20230628100438_b58-MCO-19-1-02651","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/AOG.0b013e3182964ce3","article-title":"Hormonal therapy for women with stage IA endometrial cancer of all grades","volume":"122","author":"Park","year":"2013","journal-title":"Obstet Gynecol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T10:04:45Z","timestamp":1687946685000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2023.2651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,5,25]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2023.2651","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"article-number":"55"}}